A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Monika A. Niewczas(Joslin Diabetes Center), Meda E. Pavkov(Centers for Disease Control and Prevention), Jan Skupień(Jagiellonian University), Adam M. Smiles(Joslin Diabetes Center), Zaipul I. Md Dom(Joslin Diabetes Center), Jonathan M. Wilson(Eli Lilly (United States)), Jihwan Park(University of Pennsylvania), Viji Nair(University of Michigan), Andrew Schlafly(Joslin Diabetes Center), Pierre‐Jean Saulnier(Inserm), Eiichiro Satake(Joslin Diabetes Center), Christopher A. Simeone(Joslin Diabetes Center), Hetal Shah(Joslin Diabetes Center), Chengxiang Qiu(University of Pennsylvania), Helen C. Looker(National Institute of Diabetes and Digestive and Kidney Diseases), Paolo Fiorina(Boston Children's Hospital), Carl F. Ware(Sanford Burnham Prebys Medical Discovery Institute), Jennifer K. Sun(Joslin Diabetes Center), Alessandro Doria(Joslin Diabetes Center), Matthias Kretzler(University of Michigan), Katalin Suszták(University of Pennsylvania), Kevin L. Duffin(Eli Lilly (United States)), Robert G. Nelson(National Institute of Diabetes and Digestive and Kidney Diseases), Andrzej S. Królewski(Joslin Diabetes Center)
Nature Medicine
April 22, 2019
Cited by 431Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis